Edwards Lifesciences Corporation
US ˙ NYSE ˙ US28176E1082

SecurityEW / Edwards Lifesciences Corporation
InstitutionFirst Foundation Advisors
Latest Disclosed Ownership3,834 shares
Latest Disclosed Value $ 307,027
First Foundation Advisors reports 65.59% decrease in ownership of EW / Edwards Lifesciences Corporation

On May 4, 2026 - First Foundation Advisors filed a 13F-HR form disclosing ownership of 3,834 shares of Edwards Lifesciences Corporation (US:EW) valued at $307,027 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 4, 2026 disclosing 11,141 shares of Edwards Lifesciences Corporation. This represents a change in shares of -65.59% during the quarter. The current value of the position is $329,724 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-04 2026-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 3,834 -7,307 -65.59 307 -67.65 0.0124
2026-02-04 2025-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 11,141 -28,537 -71.92 950 -69.24 0.0358
2025-11-17 2025-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 39,678 471 1.20 3,086 0.62 0.1140
2025-08-14 2025-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 39,207 905 2.36 3,066 10.45 0.1136
2025-05-08 2025-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 38,302 -1,999 -4.96 2,776 -6.94 0.1130
2025-02-13 2024-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 40,301 -626 -1.53 2,983 10.48 0.1123
2024-11-14 2024-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 40,927 31,547 336.32 2,701 211.78 0.1017
2024-08-06 2024-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 9,380 471 5.29 866 1.76 0.0331
2024-05-10 2024-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 8,909 0 0.00 851 25.33 0.0341
2024-02-14 2023-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 8,909 -3,713 -29.42 679 -22.31 0.0310
2023-11-15 2023-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 12,622 -16,852 -57.18 874 -68.56 0.0408
2023-08-14 2023-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 29,474 -181,642 -86.04 2,780 -84.08 0.1201
2023-05-12 2023-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 211,116 -3,303 -1.54 17,466 9.18 0.8031
2023-02-14 2022-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 214,419 36,046 20.21 15,998 8.54 0.7662
2022-11-14 2022-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 178,373 137,744 339.03 14,739 281.44 0.7217
2022-08-12 2022-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 40,629 6,590 19.36 3,864 -3.57 0.1707
2022-05-05 2022-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 34,039 3,744 12.36 4,007 2.09 0.1447
2022-02-14 2021-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 30,295 1,845 6.49 3,925 21.86 0.1349
2021-11-15 2021-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 28,450 3,434 13.73 3,221 24.31 0.1202
2021-08-13 2021-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 25,016 2,556 11.38 2,591 37.89 0.0998
2021-05-18 2021-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 22,460 3,398 17.83 1,879 8.05 0.0806
2021-02-16 2020-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 19,062 5,541 40.98 1,739 61.17 0.0771
2020-11-12 2020-09-30 13F Edwards Lifesciences COM 28176E108 13,521 1,262 10.29 1,079 27.39 0.0501
2020-08-14 2020-06-30 13F Edwards Lifesciences COM 28176E108 12,259 8,771 251.46 847 28.72 0.0437
2020-05-11 2020-03-31 13F Edwards Lifesciences COM 28176E108 3,488 -1,231 -26.09 658 -40.24 0.0403
2020-02-11 2019-12-31 13F Edwards Lifesciences COM 28176E108 4,719 78 1.68 1,101 7.84 0.0545
2019-11-12 2019-09-30 13F Edwards Lifesciences COM 28176E108 4,641 -2,039 -30.52 1,021 -17.26 0.0545
2019-08-14 2019-06-30 13F Edwards Lifesciences COM 28176E108 6,680 4,869 268.86 1,234 256.65 0.0691
2019-05-13 2019-03-31 13F Edwards Lifesciences COM 28176E108 1,811 -7,409 -80.36 346 -75.50 0.0205
2019-02-14 2018-12-31 13F Edwards Lifesciences COM 28176E108 9,220 7,541 449.14 1,412 383.56 0.0891
2018-11-13 2018-09-30 13F Edwards Lifesciences COM 28176E108 1,679 0 0.00 292 19.67 0.0162
2018-08-14 2018-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 1,679 -25 -1.47 244 2.52 0.0143
2018-05-15 2018-03-31 13F Edwards Lifesciences COM 28176E108 1,704 -169 -9.02 238 12.80 0.0133
2018-02-14 2017-12-31 13F Edwards Lifesciences COM 28176E108 1,873 1,873 211 0.0114
2016-05-13 2016-03-31 13F Edwards Lifesciences COM 28176E108 0 -6,596 -100.00 0 -100.00
2016-02-16 2015-12-31 13F Edwards Lifesciences COM 28176E108 6,596 2,989 82.87 521 1.56 0.0356
2015-11-16 2015-09-30 13F Edwards Lifesciences COM 28176E108 3,607 3,607 513 0.0421
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.